Annual Cash & Cash Equivalents
$49.76 M
-$8.20 M-14.15%
December 31, 2023
Summary
- As of February 8, 2025, IRMD annual cash & cash equivalents is $49.76 million, with the most recent change of -$8.20 million (-14.15%) on December 31, 2023.
- During the last 3 years, IRMD annual cash & cash equivalents has fallen by -$306.50 thousand (-0.61%).
- IRMD annual cash & cash equivalents is now -19.74% below its all-time high of $62.00 million, reached on December 31, 2021.
Performance
IRMD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$51.72 M
+$3.19 M+6.56%
September 30, 2024
Summary
- As of February 8, 2025, IRMD quarterly cash and cash equivalents is $51.72 million, with the most recent change of +$3.19 million (+6.56%) on September 30, 2024.
- Over the past year, IRMD quarterly cash and cash equivalents has increased by +$3.19 million (+6.56%).
- IRMD quarterly cash and cash equivalents is now -16.58% below its all-time high of $62.00 million, reached on December 31, 2021.
Performance
IRMD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IRMD Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -14.2% | +6.6% |
3 y3 years | -0.6% | +6.6% |
5 y5 years | +77.5% | +6.6% |
IRMD Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -19.7% | at low | -16.6% | +20.9% |
5 y | 5-year | -19.7% | +14.4% | -16.6% | +20.9% |
alltime | all time | -19.7% | +2831.8% | -16.6% | +2001.1% |
IRadimed Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $51.72 M(+6.6%) |
Jun 2024 | - | $48.54 M(+7.6%) |
Mar 2024 | - | $45.13 M(-9.3%) |
Dec 2023 | $49.76 M(-14.1%) | $49.76 M(+6.5%) |
Sep 2023 | - | $46.75 M(+2.0%) |
Jun 2023 | - | $45.82 M(+7.1%) |
Mar 2023 | - | $42.78 M(-26.2%) |
Dec 2022 | $57.96 M(-6.5%) | $57.96 M(+4.3%) |
Sep 2022 | - | $55.59 M(+6.6%) |
Jun 2022 | - | $52.16 M(+3.4%) |
Mar 2022 | - | $50.45 M(-18.6%) |
Dec 2021 | $62.00 M(+23.8%) | $62.00 M(+6.2%) |
Sep 2021 | - | $58.37 M(+5.8%) |
Jun 2021 | - | $55.16 M(+8.6%) |
Mar 2021 | - | $50.80 M(+1.5%) |
Dec 2020 | $50.07 M(+15.1%) | $50.07 M(+5.3%) |
Sep 2020 | - | $47.55 M(+4.6%) |
Jun 2020 | - | $45.46 M(+1.8%) |
Mar 2020 | - | $44.64 M(+2.7%) |
Dec 2019 | $43.48 M | $43.48 M(+12.5%) |
Sep 2019 | - | $38.64 M(+19.2%) |
Jun 2019 | - | $32.42 M(+9.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $29.68 M(+5.9%) |
Dec 2018 | $28.03 M(+53.9%) | $28.03 M(+18.3%) |
Sep 2018 | - | $23.70 M(+11.1%) |
Jun 2018 | - | $21.33 M(+6.2%) |
Mar 2018 | - | $20.09 M(+10.4%) |
Dec 2017 | $18.21 M(+2.8%) | $18.21 M(-1.1%) |
Sep 2017 | - | $18.41 M(+9.6%) |
Jun 2017 | - | $16.80 M(-3.8%) |
Mar 2017 | - | $17.46 M(-1.5%) |
Dec 2016 | $17.71 M(-8.5%) | $17.71 M(+10.7%) |
Sep 2016 | - | $16.00 M(+32.6%) |
Jun 2016 | - | $12.07 M(-22.2%) |
Mar 2016 | - | $15.51 M(-19.9%) |
Dec 2015 | $19.37 M(+104.9%) | $19.37 M(+24.7%) |
Sep 2015 | - | $15.53 M(+25.0%) |
Jun 2015 | - | $12.43 M(+15.4%) |
Mar 2015 | - | $10.77 M(+14.0%) |
Dec 2014 | $9.45 M(+284.1%) | $9.45 M(-47.8%) |
Sep 2014 | - | $18.11 M(+325.1%) |
Jun 2014 | - | $4.26 M(+46.5%) |
Mar 2014 | - | $2.91 M(+18.2%) |
Dec 2013 | $2.46 M(+45.0%) | $2.46 M |
Dec 2012 | $1.70 M | - |
FAQ
- What is IRadimed annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for IRadimed?
- What is IRadimed annual cash & cash equivalents year-on-year change?
- What is IRadimed quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for IRadimed?
- What is IRadimed quarterly cash and cash equivalents year-on-year change?
What is IRadimed annual cash & cash equivalents?
The current annual cash & cash equivalents of IRMD is $49.76 M
What is the all time high annual cash & cash equivalents for IRadimed?
IRadimed all-time high annual cash & cash equivalents is $62.00 M
What is IRadimed annual cash & cash equivalents year-on-year change?
Over the past year, IRMD annual cash & cash equivalents has changed by -$8.20 M (-14.15%)
What is IRadimed quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IRMD is $51.72 M
What is the all time high quarterly cash and cash equivalents for IRadimed?
IRadimed all-time high quarterly cash and cash equivalents is $62.00 M
What is IRadimed quarterly cash and cash equivalents year-on-year change?
Over the past year, IRMD quarterly cash and cash equivalents has changed by +$3.19 M (+6.56%)